# Mastec Inc: financial statements, quarterly

MTZ · NYSE · CIK 15615 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mtz.md) · [Financials](/companies/mtz/financials.md) · [Filings](/companies/mtz/filings.md) · [Insiders](/companies/mtz/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mtz/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,280 d](/filings/0000015615-26-000020.md) | [2,687](/filings/0000015615-25-000052.md) | [2,961](/filings/0000015615-25-000079.md) | [3,252](/filings/0000015615-25-000128.md) | [3,403 d](/filings/0000015615-26-000020.md) | [2,848](/filings/0000015615-26-000050.md) | [3,545](/filings/0000015615-26-000093.md) | [3,967](/filings/0000015615-26-000125.md) | [3,940 d](/filings/0000015615-26-000020.md) | [3,829](/filings/0000015615-26-000050.md) | [4,374](/filings/0000015615-26-000093.md) | [5,152](/filings/0000015615-26-000125.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | [36.2](/filings/0000015615-26-000050.md) | [158](/filings/0000015615-26-000093.md) | [250](/filings/0000015615-26-000125.md) | not reported | [142](/filings/0000015615-26-000050.md) | [226](/filings/0000015615-26-000093.md) | [275](/filings/0000015615-26-000125.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | [39.0](/filings/0000015615-26-000050.md) | [43.9](/filings/0000015615-26-000093.md) | [45.4](/filings/0000015615-26-000125.md) | not reported | [43.5](/filings/0000015615-26-000050.md) | [47.2](/filings/0000015615-26-000093.md) | [61.8](/filings/0000015615-26-000125.md) |
| Income tax | $m | [(1.2) d](/filings/0000015615-26-000020.md) | [(11.1)](/filings/0000015615-25-000052.md) | [19.3](/filings/0000015615-25-000079.md) | [31.5](/filings/0000015615-25-000128.md) | [11.7 d](/filings/0000015615-26-000020.md) | [(3.4)](/filings/0000015615-26-000050.md) | [30.7](/filings/0000015615-26-000093.md) | [45.1](/filings/0000015615-26-000125.md) | [21.0 d](/filings/0000015615-26-000020.md) | [21.8](/filings/0000015615-26-000050.md) | [48.0](/filings/0000015615-26-000093.md) | [52.4](/filings/0000015615-26-000125.md) |
| Net income | $m | [0.8 d](/filings/0000015615-26-000020.md) | [(41.2)](/filings/0000015615-25-000052.md) | [34.0](/filings/0000015615-25-000079.md) | [95.2](/filings/0000015615-25-000128.md) | [74.7 d](/filings/0000015615-26-000020.md) | [9.9](/filings/0000015615-26-000050.md) | [85.8](/filings/0000015615-26-000093.md) | [161](/filings/0000015615-26-000125.md) | [143 d](/filings/0000015615-26-000020.md) | [60.8](/filings/0000015615-26-000050.md) | [130](/filings/0000015615-26-000093.md) | [151](/filings/0000015615-26-000125.md) |
| Diluted EPS | $ per share | not reported | [(0.53)](/filings/0000015615-25-000052.md) | [0.43](/filings/0000015615-25-000079.md) | [1.21](/filings/0000015615-25-000128.md) | not reported | [0.13](/filings/0000015615-26-000050.md) | [1.09](/filings/0000015615-26-000093.md) | [2.04](/filings/0000015615-26-000125.md) | not reported | [0.77](/filings/0000015615-26-000050.md) | [1.65](/filings/0000015615-26-000093.md) | [1.89](/filings/0000015615-26-000125.md) |
| Basic EPS | $ per share | not reported | [(0.53)](/filings/0000015615-25-000052.md) | [0.44](/filings/0000015615-25-000079.md) | [1.22](/filings/0000015615-25-000128.md) | not reported | [0.13](/filings/0000015615-26-000050.md) | [1.10](/filings/0000015615-26-000093.md) | [2.07](/filings/0000015615-26-000125.md) | not reported | [0.78](/filings/0000015615-26-000050.md) | [1.67](/filings/0000015615-26-000093.md) | [1.90](/filings/0000015615-26-000125.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0000015615-25-000021.md) | [0.2](/filings/0000015615-24-000045.md) | [0.3](/filings/0000015615-24-000075.md) | [0.2](/filings/0000015615-24-000107.md) | [0.4](/filings/0000015615-26-000020.md) | [0.3](/filings/0000015615-25-000052.md) | [0.2](/filings/0000015615-25-000079.md) | [0.2](/filings/0000015615-25-000128.md) | [0.4](/filings/0000015615-26-000125.md) | [0.3](/filings/0000015615-26-000050.md) | [0.3](/filings/0000015615-26-000093.md) | [0.5](/filings/0000015615-26-000125.md) |
| Current assets | $bn | [4.0](/filings/0000015615-25-000021.md) | [3.4](/filings/0000015615-24-000045.md) | [3.5](/filings/0000015615-24-000075.md) | [3.6](/filings/0000015615-24-000107.md) | [3.7](/filings/0000015615-26-000020.md) | [3.5](/filings/0000015615-25-000052.md) | [3.7](/filings/0000015615-25-000079.md) | [4.3](/filings/0000015615-25-000128.md) | [4.3](/filings/0000015615-26-000125.md) | [4.5](/filings/0000015615-26-000050.md) | [4.9](/filings/0000015615-26-000093.md) | [6.2](/filings/0000015615-26-000125.md) |
| Total assets | $bn | [9.4](/filings/0000015615-26-000020.md) | [8.7](/filings/0000015615-24-000045.md) | [8.7](/filings/0000015615-24-000075.md) | [8.8](/filings/0000015615-24-000107.md) | [9.0](/filings/0000015615-26-000020.md) | [8.9](/filings/0000015615-25-000052.md) | [9.1](/filings/0000015615-25-000079.md) | [9.7](/filings/0000015615-25-000128.md) | [9.9](/filings/0000015615-26-000125.md) | [10.4](/filings/0000015615-26-000050.md) | [10.9](/filings/0000015615-26-000093.md) | [14.1](/filings/0000015615-26-000125.md) |
| Current liabilities | $bn | [2.8](/filings/0000015615-25-000021.md) | [2.6](/filings/0000015615-24-000045.md) | [2.7](/filings/0000015615-24-000075.md) | [2.9](/filings/0000015615-24-000107.md) | [3.0](/filings/0000015615-26-000020.md) | [2.9](/filings/0000015615-25-000052.md) | [3.1](/filings/0000015615-25-000079.md) | [3.2](/filings/0000015615-25-000128.md) | [3.3](/filings/0000015615-26-000125.md) | [3.4](/filings/0000015615-26-000050.md) | [3.5](/filings/0000015615-26-000093.md) | [4.5](/filings/0000015615-26-000125.md) |
| Total liabilities | $bn | [6.7](/filings/0000015615-25-000021.md) | [6.1](/filings/0000015615-24-000045.md) | [5.9](/filings/0000015615-24-000075.md) | [5.9](/filings/0000015615-24-000107.md) | [6.0](/filings/0000015615-26-000020.md) | [5.9](/filings/0000015615-25-000052.md) | [6.1](/filings/0000015615-25-000079.md) | [6.5](/filings/0000015615-25-000128.md) | [6.6](/filings/0000015615-26-000125.md) | [7.0](/filings/0000015615-26-000050.md) | [7.3](/filings/0000015615-26-000093.md) | [9.9](/filings/0000015615-26-000125.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [2.7](/filings/0000015615-25-000021.md) | [2.7](/filings/0000015615-24-000045.md) | [2.7](/filings/0000015615-24-000075.md) | [2.8](/filings/0000015615-24-000107.md) | [2.9](/filings/0000015615-26-000020.md) | [2.9](/filings/0000015615-25-000052.md) | [2.9](/filings/0000015615-25-000079.md) | [3.1](/filings/0000015615-25-000128.md) | [3.3](/filings/0000015615-26-000125.md) | [3.3](/filings/0000015615-26-000050.md) | [3.5](/filings/0000015615-26-000093.md) | [4.1](/filings/0000015615-26-000125.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [491 d](/filings/0000015615-26-000020.md) | [108](/filings/0000015615-25-000052.md) | [264 d](/filings/0000015615-25-000079.md) | [278 d](/filings/0000015615-25-000128.md) | [472 d](/filings/0000015615-26-000020.md) | [78.4](/filings/0000015615-26-000050.md) | [5.6 d](/filings/0000015615-26-000093.md) | [89.0 d](/filings/0000015615-26-000125.md) | [373 d](/filings/0000015615-26-000020.md) | [98.9](/filings/0000015615-26-000050.md) | [21.5 d](/filings/0000015615-26-000093.md) | [267 d](/filings/0000015615-26-000125.md) |
| Capital expenditure | $m | [35.6 d](/filings/0000015615-26-000020.md) | [25.4](/filings/0000015615-25-000052.md) | [31.5](/filings/0000015615-25-000079.md) | [43.6](/filings/0000015615-25-000128.md) | [48.3 d](/filings/0000015615-26-000020.md) | [47.3](/filings/0000015615-26-000050.md) | [63.8](/filings/0000015615-25-000079.md) | [68.7](/filings/0000015615-25-000128.md) | [80.2 d](/filings/0000015615-26-000020.md) | [96.8](/filings/0000015615-26-000050.md) | [91.5 d](/filings/0000015615-26-000093.md) | [87.3 d](/filings/0000015615-26-000125.md) |
| Share repurchases | $m | [0.0 d](/filings/0000015615-26-000020.md) | [0.0](/filings/0000015615-25-000052.md) | [0.0 d](/filings/0000015615-25-000079.md) | [0.0 d](/filings/0000015615-25-000128.md) | [0.0 d](/filings/0000015615-26-000020.md) | [26.8](/filings/0000015615-26-000050.md) | [50.5 d](/filings/0000015615-26-000093.md) | [0.0 d](/filings/0000015615-26-000125.md) | [0.0 d](/filings/0000015615-26-000020.md) | [0.0](/filings/0000015615-26-000050.md) | [0.0 d](/filings/0000015615-26-000093.md) | [0.0 d](/filings/0000015615-26-000125.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [77.0](/filings/0000015615-24-000045.md) | [78.4](/filings/0000015615-24-000075.md) | [78.5](/filings/0000015615-24-000107.md) | [77.9](/filings/0000015615-25-000052.md) | [78.9](/filings/0000015615-25-000079.md) | [78.9](/filings/0000015615-25-000128.md) | [79.1](/filings/0000015615-26-000050.md) | [78.5](/filings/0000015615-26-000093.md) | [78.6](/filings/0000015615-26-000125.md) | [78.8](/filings/0000015615-26-000050.md) | [78.9](/filings/0000015615-26-000093.md) | [79.8](/filings/0000015615-26-000125.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 80,300,833 at 2026-10-26, from the cover of the [10-Q filed 2026-10-29](/filings/0000015615-26-000125.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 19:10 ET. No prices; not investment advice.